Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models

Integrative Cancer Therapies

Volumn 5, Issue 4, 2006, Pages 362-372

  MacLaughlin, Brian W ^a   Gutsmuths, Babett ^a   Pretner, Ewald ^a   Jonas, Wayne B ^b   Ives, John ^b   Kulawardane, Don Victor ^c   Amri, Hakima ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b SAMUELI INSTITUTE   (United States)

^c Homeopathic Clinic   (Sri Lanka)

Author keywords

Conium maculatum; Human prostate and breast cancer cell lines; Nude mice; Prostate cancer; Sabal serrulata; Thuja occidentalis

Indexed keywords

ANTINEOPLASTIC AGENT; CEDAR LEAF OIL; CONIUM MACULATUM EXTRACT; HERBACEOUS AGENT; SABAL EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONIUM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HOMEOPATHY; HUMAN; HUMAN CELL; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SABAL; STATISTICAL SIGNIFICANCE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CONIUM; DISEASE MODELS, ANIMAL; FEMALE; HOMEOPATHY; HUMANS; MALE; MICE; MICE, NUDE; PHYTOTHERAPY; PLANT PREPARATIONS; PROSTATIC NEOPLASMS; SERENOA; THUJA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33750868009     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406295350     Document Type: Article

References (56)

1. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2005.
2. Dearnaley DP, Sydes MR, Mason MD, et al. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J Natl Cancer Inst. 2003;95(17):1300-1311.
3. Hamdy FC. Prognostic and predictive factors in prostate cancer. Cancer Treat Rev. 2001;27(3):143-151.
4. Kronz JD, Milord R, Wilentz R, Weir EG, Schreiner SR, Epstein JI. Lesions missed on prostate biopsies in cases sent in for consultation. Prostate. 2003;54(4):310-314.
5. Wei J, Gravlin K, Cooney KA. Re: Osteoporosis after orchiectomy for prostate cancer. J Urol. 1998;160(5):1809.
6. Deftos LJ. Prostate carcinoma: production of bioactive factors. Cancer. 2000;88(12 Suppl):3002-3008.
7. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349(4):366-381.
8. Farnsworth NR, Morris RW. Higher plants - the sleeping giant of drug development. Am J Pharm Sci Support Public Health. 1976;148(2):46-52.
9. Barberis L, de Toni E, Schiavone M, Zicca A, Ghio R. Unconventional medicine teaching at the Universities of the European Union. J Altern Complement Med. 2001;7(4):337-343.
10. Fisher P. Homeopathy: a multifaceted scientific renaissance. J Altern Complement Med. 2001;7(2):123-125.
11. Davenas E, Beauvais F, Amara J, et al. Human basophil degranulation triggered by very dilute antiserum against IgE. Nature. 1988;333(6176):816-818.
12. Hirst SJ, Hayes NA, Burridge J, Pearce FL, Foreman JC. Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature. 1993;366(6455):525-527.
13. Belon P, Cumps J, Ennis M, et al. Histamine dilutions modulate basophil activation. Inflamm Res. 2004;53(5):181-188.
14. Lorenz I, Schneider EM, Stolz P, Brack A, Strube J. Influence of the diluent on the effect of highly diluted histamine on basophil activation. Homeopathy. 2003;92(1):11-18.
15. Lapp C, Wurmser L, Ney J. Infinitesimal doses of sodium arseniate causing mobilization of fixed arsenic in guinea pigs. Therapie. 1955;10(4):625-638.
16. Cazin JC, Cazin M, Gaborit JL, et al. A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat. Hum Toxicol. 1987;6(4):315-320.
17. Bildet J, Guere JM, Saurel J, Aubin M, Demerque D, Quilichini R. Etude de l'action de differentes dilutions de phosphorus sur l'hepatite toxique du rat. Ann Homeop Fr. 1975;17(4):425-430.
18. Bildet J, Aubin M, Baronnet S, Berjon JJ, Gomez H, Manlhiot JL. Resistance de la cellule hepatique du rat apres une intoxication infinitesimale au tetrachlorure de carbone. Homeop Francaise. 1984;72:211-216.
19. Cambar J, Desmouliere A, Cal JC, Guillemain J. Mise en evidence de l'effet protecteur de dilutions homeopathiques de Mercurius corrosivus vis-a-vis de la mortalite au chlorure mercurique chez la souris. Ann Homeop Fr. 1983;25(5):160-165.
20. Bastide P, Aubin M, Baronnet S. Etude pharmacologique d'une preparation d'Apis mel. (7CH) vis-a-vis de l'erytheme aux rayons UV chez le cobayes albinos. Ann Homeop Fr. 1975;17(3):289-294.
21. Bildet J, Guyot M, Bonini F, Grignon MC, Pointevin B, Quilichini R. Demonstrating the effects of Apis mellifica and Apium virus dilutions on erythema induced by UV radiation on guinea pigs. Berlin J Res Homeop. 1990;1:28-36.
22. Delbancut A, Dorfman P, Cambar J. Protective effect of very low concentrations of heavy metals (cadmium and cisplatin) against cytotoxic doses of these metals on renal tubular cell cultures. Br Homeop J. 1993;82:123-129.
23. Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport. 2001;12(2):335-339.
24. Pathak S, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol. 2003;23(4):975-982.
25. Biswas SJ, Khuda-Bukhsh AR. Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Complement Altern Med. 2002;2:4.
26. Biswas SJ, Pathak S, Bhattacharjee N, Das JK, Khuda-Bukhsh AR. Efficacy of the potentized homeopathic drug, Carcinosin 200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p- dimethylaminoazobenzene-induced hepatocarcinogenesis in mice. J Altern Complement Med. 2005;11(5):839-854.
27. Sato DY, Wal R, de Oliveira CC, et al. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy. 2005;94(1):26-32.
28. Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate. 1996;29(4):231-240; discussion 41-42.
29. Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology. 1998;51(6):1003-1007.
30. Gerber GS, Fitzpatrick JM. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int. 2004;94(3):338-344.
31. Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354(6):557-566.
32. Richardson MA, White JD. Complementary/alternative medicine and cancer research. A national initiative. Cancer Pract. 2000;8(1):45-48.
33. Kao GD, Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 2000;88(3):615-619.
34. Blumenthal M. The Complete German Commission E Monographs - Tlierapeutic Guide to Herbal Medicines. 1st ed. Austin, TX: American Botanical Council; 1998.
35. Vozianov AF, Simeonova NK. [Homeopathic treatment of patients with prostate gland adenoma]. Vrach Delo. 1989(2):5-8.
36. Pecherskii AV, Aleksandrov VP, Mazurov VI, Kniaz'kin IV, Zeziulin PN, Nikolaeva EV. [Treatment of benign prostatic hyperplasia with the preparation Gentos]. Urologiia. 2000(5):16-17.
37. Baran D. [Arbor vitae, a guarantee of health]. Rev Med Chir Soc Med Nat Iasi. 1991;95(3-4):347-349.
38. Gohla SH, Zeman RA, Bogel M. Modification of the in vitro replication of the human immunodeficiency virus HIV-1 by TPSg, a polysaccharide fraction isolated from the Cupressaceae Thuja occidentalis L. (Arborvitae). Haematol Blood Transfus. 1992;35:140-149.
39. Gohla SH, Haubeck HD, Neth RD. Mitogenic activity of high molecular polysaccharide fractions isolated from the Cupressaceae Thuja occidentale L. I. Macrophage-dependent induction of CD-4-positive T-helper (Th+) lymphocytes. Leukemia. 1988;2(8):528-533.
40. Naser B, Bodinet C, Tegmeier M, Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. eCAM. 2005;2(1):69-78.
41. Sunila E, Kuttan G. Protective effect of Thuja occidentalis against radiation-induced toxicity in mice. Integr Cancer Ther. 2005;4(4):322-328.
42. Iwamoto M, Minami T, Tokuda H, Ohtsu H, Tanaka R. Potential antitumor promoting diterpenoids from the stem bark of Thuja standishii. Planta Med. 2003;69(1):69-72.
43. Valsa JO, Felzenszwalb I. Genotoxic evaluation of the effect of Thuya occidentalys tinctures. Braz J Biol. 2001;61(2):329-332.
44. Vetter J. Poison hemlock (Conium maculatum L.). Food Chem Toxicol. 2004;42(9):1373-1382.
45. Herscu P, Ryan C. The cycle of Conium maculatum. N Engl J Homeop. 1997;6(1). Available at: www.nesh.com/main/nejh/samples/conium.html.
46. Reynolds T. Hemlock alkaloids from Socrates to poison aloes. Phytochemistry. 2005;66(12):1399-1406.
47. Cooper D. Origin and history of carcinosin. Br Homeop J. 1982;71(10):20.
48. Smits T, ed. Pratcical Materia Medica for the consulting room. 2nd ed. Waalre, Netherlands: Smits-Vanhove; 1993.
49. Gaddipati JP, Mani H, Shefali, et al. Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res. 2000;20(4):2547-2552.
50. Stephenson J. Review of investigations into the action of substances in dilutions greater than 1 x 10(-24) (microdilutions). Br Homeop J. 1973;62:3-18.
51. Witt C. Using Methods of Physics to Study Homeopathic High Potencies. Essen, Germany: KVC Verlag; 2000.
52. Zacharias C. Implications of contaminants to scientific research in homeopathy. Br homeopathic J. 1995;84:3-5.
53. Witt CM, Ludtke R, Weisshuhn TE, Quint P, Willich SN. The role of trace elements in homeopathic preparations and the influence of container material, storage duration, and potentisation. Forsch Komplementarmed. 2006;13(1):15-21.
54. Demangeat J, Gries P, Pointevin B. Low-field NMR water proton longitudinal relaxation in ultrahigh diluted aqueous solutions of silica-lactose prepared in glass material for pharmaceutical use. Appl Magnet Resonance. 2004;26:465-481.
55. Jonas W, Dillner D. Protection of mice from tularemia infection with ultra-low, serial agitated dilutions prepared from Francisella tularensis-infected tissue. J Sci Explor. 2000;14:35-52.
56. Aabel S, Fossheim S, Rise F. Nuclear magnetic resonance (NMR) studies of homeopathic solutions. Br Homeopath J. 2001;90(1):14-20.